'Statement by Yes To Life: Your article referred to Yes To Life and quoted negative opinions about Vitamin C cancer treatments. In fact, considering there are no big profits to be made from Vitamin C, unlike a new drug, and therefore no commercial interest in research, there is actually an impressive body of evidence including laboratory, animal and human trials. Its safety combined with usefulness against both cancer and the side effects of standard treatments, makes a good case for considering Vitamin C as part of a treatment programme. Our charity provides information and contacts and helps many people to pay for treatments which are reasonably priced at around £200 per two-hour session including the cost of supervising doctor, nurse and clinic. - Robin Daly, Chairman, Yes To Life '
Vitamin C and Cancer
This all adds up to a very compelling case for considering Vitamin C as part of a cancer programme. And as you can see, it is far from the case that “‘There is no evidence at all.” as stated by the MoS ‘experts’. The sum of the evidence for Vitamin C would, within the hierarchy of evidence, be classed as ‘emerging’. Yet this is hardly a basis for dismissing it wholesale, when it has an incredible safety record. By contrast, emerging evidence for a drug with potentially harmful side effects would be a major hot topic, with rules being bent and red tape slashed in the rush to get it to people dying from cancer.
Read more blogs from Robin here.